Work

Cost-effectiveness analysis of the addition of bevacizumab to chemotherapy as induction and maintenance therapy for metastatic non-squamous non-small-cell lung cancer

Year: 2017

Type: article

Source: Clinical & Translational Oncology

DOI: 10.1007/s12094-017-1715-1

Authors: H. Zheng, L. Xie, M. Zhan, F. Wen, T. Xu, Q. Li

Institutions: Sichuan University, West China Hospital of Sichuan University, West China Medical Center of Sichuan University

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2744137087

FWCI: 3.689

Cites: 24

Cited by: 35

Related to: 10